The Alliance for Addiction Payment Reform, of which the AHA is a member, is partnering with health care providers and payers to test an alternative payment model for addiction treatment and recovery in Connecticut, Kentucky, North Carolina, Tennessee, Texas and Washington, D.C. The Addiction Recovery Medical Home model aims to reduce health care costs and improve outcomes by addressing a broad continuum of care, from emergent and stabilizing acute-care settings to community-based services and recovery supports.
 
“Nuvance Health is very excited to partner with national thought leaders to redesign how substance use disorders are treated and reimbursed,” said John Murphy, M.D., CEO of Nuvance Health, an AHA member based in Danbury, Conn. “By shifting dollars from the acute care setting to the outpatient setting with linkages into the communities we are able to better serve our population by managing the full continuum of care from prevention to chronic disease management. This approach offers an effective, patient-centered focus for this often-overlooked population.” 
 
The Alliance also plans to pilot the model in additional areas of the country. For more on the model and its episodes of care, visit www.incentivizerecovery.org.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Sept. 5 published a list of participants for the Transforming Episode Accountability Model. TEAM is a…
Headline
The AHA, 340B Health and the American Society of Health-System Pharmacists last week filed an amicus brief in a federal district court in Missouri, defending…
Headline
If Johnson & Johnson moves forward with its plan to undermine the 340B Drug Pricing Program by unilaterally imposing a rebate model rather than the…
Headline
If Johnson & Johnson moves forward with its plan to undermine the 340B Drug Pricing Program by unilaterally imposing a rebate model rather than the…
Headline
Johnson & Johnson announced Aug. 23 that it would be fundamentally changing the way it makes 340B pricing available for two of its most popular products,…
Headline
The Centers for Medicare & Medicaid Aug. 15 announced it negotiated lower prices with drug makers for 10 high-cost, sole-source drugs, with the new prices…